Streetbeat News

Earnings

XLO

Xilio Therapeutics reported a Q4 2023 EPS of $(0.64), an improvement from $(0.82) in the same quarter the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:29 pm

GVP

GSE Systems (NASDAQ:GVP) reported Q4 earnings with losses of $(0.28) per share, surpassing the $(0.81) estimate, marking a 65.43% beat and a 44% improvement year-over-year. However, their quarterly sales of $10.21M fell short of the $12.07M estimate by 15.37%, representing a 5.56% decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

April 01, 2024 | 8:29 pm

TNXP

Tonix Pharmaceuticals reported Q4 earnings with losses of $(0.86) per share, surpassing the $(1.55) estimate, marking a 75.43% improvement from last year. However, their sales of $3.80M fell short of the $5.75M estimate.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:28 pm

ZOM

Zomedica reported Q4 2023 GAAP EPS of $(0.02) and sales of $7.337M, surpassing the $7.000M sales estimate. This represents a 19.17% increase over the previous year's sales of $6.157M.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:28 pm

ASTS

AST SpaceMobile reported a fiscal year loss per share of $(1.07), compared to last year's loss of $(0.58).

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:27 pm

PVH

PVH Corp (NYSE:PVH) reported Q4 earnings with an EPS of $3.72, beating estimates by 5.0% against an expected $3.53. Revenue increased by $900 thousand year-over-year. The company has a history of surpassing EPS estimates, which previously led to a 7% stock price increase the following day. This performance continues PVH's trend of exceeding earnings expectations.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 8:25 pm

YTEN

Yield10 Bioscience (NASDAQ:YTEN) reported Q4 earnings with an EPS of $-0.27, beating estimates by 10.0% but with a revenue decrease of $87K from the previous year. The company's past earnings performance shows a pattern of missed EPS estimates leading to share price drops.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 8:25 pm

AAME

Atlantic American Corporation (AAME) reported a Q4 net loss of $2.2 million, or ($0.11) per diluted share, compared to a net income of $1.0 million, or $0.05 per diluted share, in the same period last year. Annual revenue increased to $46.75M from $45.23M YoY, but the company experienced a net loss of $0.2 million for the year, down from a net income of $1.5 million in the previous year. The losses were attributed to increased insurance benefits and losses, higher debt service costs due to rising interest rates, and a decrease in earned premiums. Despite these challenges, the company announced an annual dividend of $0.02 per share, payable in April 2024.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:24 pm

PVH

PVH Corp's shares are trading lower following the announcement of its Q4 financial results and the issuance of future guidance.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:24 pm

PTIX

Protagenic Therapeutics reported a fiscal year 2023 earnings per share (EPS) of $(1.15), a decrease from the previous year's $(0.82).

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:24 pm